← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 31, 2025Last known activity
Oct 31, 2025
Timeline
2020s
- Jan 1, 2023
Retension Pharmaceuticals. Inc.— Founded
Drugs by trial phase (1 distinct, 1 trials)
Phase 2 (1 own, 0 via acquisition)
Recent trials (1)
- NCT07142356Lead sponsorPhase 2Oct 31, 2025
Details
- Founded
- Falls Church, VA, US Jan 1, 2023
- Last known activity
- Oct 31, 2025